Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Post by steadfaston Jun 03, 2014 1:42pm
233 Views
Post# 22625564

a QUESTION FOR NOPOO

a QUESTION FOR NOPOOCan you please explain:
1.  What has happened to the 1st patient who had islets transplanted in Aug 2012?
Does patient still have cell pouch?  I realize Trial 1 is completed and safety proven.
Does that mean this patient no longer involved?  If still involved coming up to 2 yrs.
2.  What happened to patient #2 who had islets transplanted in 2012?  Again, if still
involved coming up to 2 yrs.    Something to brag about.
3.  Am I to assume only 2 patients in Trial 1.
4.  How many patients in Trial 2. 
5.  Dr T talks about 30 day islet survival.  April 22 - one of the patients beyond 180 day
that must mean islet survival more than 30 days.
6.  Dr S refers to up to 20 patients in Phase 1/11.  Surely with results expected by fall
we must be up to 20 patients now,  can you confirm?
Did not learn anything new in todays NR other than Cathy Steiner left and new
interim CFO.  Anything you can shed light on would be appreciated.
Steadfast
Bullboard Posts